[go: up one dir, main page]

MA26531A1 - Composition pharmaceutique - Google Patents

Composition pharmaceutique

Info

Publication number
MA26531A1
MA26531A1 MA25211A MA25211A MA26531A1 MA 26531 A1 MA26531 A1 MA 26531A1 MA 25211 A MA25211 A MA 25211A MA 25211 A MA25211 A MA 25211A MA 26531 A1 MA26531 A1 MA 26531A1
Authority
MA
Morocco
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
MA25211A
Other languages
English (en)
French (fr)
Inventor
Alan Frank Parr
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of MA26531A1 publication Critical patent/MA26531A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
MA25211A 1997-08-19 1998-08-12 Composition pharmaceutique MA26531A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9717428.8A GB9717428D0 (en) 1997-08-19 1997-08-19 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
MA26531A1 true MA26531A1 (fr) 2004-12-20

Family

ID=10817619

Family Applications (1)

Application Number Title Priority Date Filing Date
MA25211A MA26531A1 (fr) 1997-08-19 1998-08-12 Composition pharmaceutique

Country Status (15)

Country Link
EP (1) EP1007010A2 (pt)
JP (1) JP2002511101A (pt)
KR (1) KR20010014080A (pt)
CN (1) CN1263461A (pt)
AR (1) AR016629A1 (pt)
AU (1) AU9343098A (pt)
BR (1) BR9810458A (pt)
CA (1) CA2295016A1 (pt)
CO (1) CO4960657A1 (pt)
GB (1) GB9717428D0 (pt)
MA (1) MA26531A1 (pt)
PE (1) PE105699A1 (pt)
TR (1) TR199903209T2 (pt)
WO (1) WO1999008666A2 (pt)
ZA (1) ZA987392B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IS6633A (is) * 2002-11-22 2004-05-23 Omega Farma Ehf. Samsetningar af fínasteríð töflum
CN102552917A (zh) 2003-08-13 2012-07-11 比奥孔有限公司 用于治疗剂的微-粒子脂肪酸盐固体剂量制剂
WO2005066195A1 (de) * 2004-01-02 2005-07-21 Pharmacon Forschung Und Beratung Gmbh Verfahren zur herstellung von 1,2-ungesättigten azasteroiden
WO2006055659A2 (en) * 2004-11-15 2006-05-26 Smithkline Beecham Corporation Fixed dose combination op dutasteride and tamsulosin
WO2010117873A2 (en) 2009-04-06 2010-10-14 Banner Pharmacaps, Inc. Progesterone solutions for increased bioavailability
ES2385240B1 (es) 2010-07-26 2013-09-23 Gp-Pharm, S.A. Cápsulas de principios activos farmacéuticos y ácidos grasos poliinsaturados para el tratamiento de enfermedades de la próstata.
US8900631B2 (en) 2011-04-28 2014-12-02 Health Science Funding, LLC Dosage form to increase prasterone bioavailability
CN103169712B (zh) * 2011-12-20 2017-10-27 重庆华邦制药有限公司 提高生物利用度的度他雄胺制剂及其制备方法
WO2014002015A1 (en) 2012-06-25 2014-01-03 Ranbaxy Laboratories Limited Pharmaceutical composition comprising dutasteride
ES2555485T1 (es) 2014-05-26 2016-01-04 Galenicum Health S.L. Composiciones farmacéuticas que contienen un agente activo
KR101679992B1 (ko) 2015-12-31 2016-11-28 주식회사 유유제약 프로필렌글리콜 모노라우레이트를 포함하는 두타스테리드의 약학적 조성물 및 이의 제조 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571817A (en) * 1984-02-27 1996-11-05 Merck & Co., Inc. Methods of treating androgenic alopecia with finasteride [17β-N-mono-substituted-carbamoyl-4-aza-5-α-androst-1-en-ones]
DE3607651A1 (de) * 1986-03-06 1987-09-10 Schering Ag Kombination von aromatasehemmer und testosteron-5(alpha)-reduktase-hemmer
TW369521B (en) * 1993-09-17 1999-09-11 Smithkline Beecham Corp Androstenone derivative
TW408127B (en) * 1993-09-17 2000-10-11 Glaxo Inc Androstenones
US5550134A (en) * 1995-05-10 1996-08-27 Eli Lilly And Company Methods for inhibiting bone loss

Also Published As

Publication number Publication date
WO1999008666A3 (en) 1999-04-15
CN1263461A (zh) 2000-08-16
KR20010014080A (ko) 2001-02-26
CO4960657A1 (es) 2000-09-25
AR016629A1 (es) 2001-07-25
AU9343098A (en) 1999-03-08
WO1999008666A2 (en) 1999-02-25
GB9717428D0 (en) 1997-10-22
PE105699A1 (es) 1999-11-25
ZA987392B (en) 2000-02-17
EP1007010A2 (en) 2000-06-14
BR9810458A (pt) 2000-09-05
TR199903209T2 (xx) 2000-05-22
CA2295016A1 (en) 1999-02-25
JP2002511101A (ja) 2002-04-09

Similar Documents

Publication Publication Date Title
ID22891A (id) Komposisi farmasi untuk kombinasi piperidinoalkanol-dekongestan
DZ2516A1 (fr) Composition pharmaceutique en aérosol.
NO962606D0 (no) Farmasöytisk sammensetning
FI955311L (fi) Farmaseuttinen koostumuspohja
NO980546D0 (no) Farmasöytiske midler
IS5331A (is) Ný lyfjablanda
EP0907644A4 (en) PHARMACEUTICAL PREPARATION
BR9507768A (pt) Composição farmacêutica
MA26531A1 (fr) Composition pharmaceutique
ID29294A (id) Komposisi farmasi
FI973229A7 (fi) Uusi farmaseuttinen koostumus
LV11727A (lv) Farmaceitiska kompozicija
ID18698A (id) Komposisi farmasi
ID25857A (id) Komposisi farmasi
FI973280A7 (fi) Farmaseuttinen koostumus
ITMI962628A0 (it) Composizione farmaceutica
BR9605777A (pt) Composição farmacêutica
ID23531A (id) Komposisi farmasi
BR9605131A (pt) Composição farmacêutica
SE9402924D0 (sv) Novel pharmaceutical composition
BR1100755A (pt) composição farmacêutica
BR1101151A (pt) Compostos e composição farmacêutica
KR960016881A (ko) 제약 조성물
SE9402437D0 (sv) Pharmaceutical composition
ID21180A (id) Senyawa-senyawa farmasi